Diary - News
All news Imaxio strengthens its intellectual property
Imaxio strengthens the intellectual property of its vaccines pipeline with two new patents granted in the United States. They offer Imaxio additional cover on the American market for the new generation of its antigen re-engineering technology, and for its influenza vaccine candidate.
